A vaccine for adult Shingles was approved in 2006 by the FDA and is in use today. Yet delivery of this vaccination has not been as widespread as it could and should be. With this in mind, many hospitals and clinics are working to improve on their current approach to its distribution; at some health centers, this includes allowing pharmacists to administer the vaccine. Can this program be implemented nationwide, in accordance with local and state laws? Would this program necessitate any change in insurance coverage for providers?
Learn more from Dr. Michael Oxman, professor of medicine and pathology at the University of California, San Diego School of Medicine, and Dr. William Schaffner, professor and chair of preventive medicine at Vanderbilt University School of Medicine. Will this program also lower overall immunization costs? Dr. Mark Nolan Hill hosts.